L&G Pharma Breakthrough UCITS ETF
ETLI.DE
#3136
ETF rank
A$32.07 M
Marketcap
๐Ÿ‡ช๐Ÿ‡บ EU
Market
A$21.03
Share price
-0.80%
Change (1 day)
14.72%
Change (1 year)

Expense ratio and fees for L&G Pharma Breakthrough UCITS ETF (ETLI.DE)

Total Expense Ratio

Total Expense Ratio as of November 2025: 0.49%

ter

ter as of August 2026: 0.49%